Sanofi Becomes the Latest Drug Maker to Announce Insulin Price Cuts

March 29, 2023

Softbank now has $5B stake in Roche for its ability to develop drugs using data

August 20, 2021

AstraZeneca abandons phase 2 sickle cell medication and pays $185 million to rejoin the oral obesity gold rush market

November 10, 2023

Must Read

Top 10 Metrics Clinical Operations Leaders Should Track

October 27, 2026

Menarini’s Stemline Signs Huge Deal With Georgiamine For Preclincal Cancer Drug

October 27, 2026

Roivant Sets Sights on Humira as Lisraya Performs Well in Eye Disease Study

October 27, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Argenx Scraps Phase III Sjögren Study Over Predicted Efficacy Failure

Novo Launches Late-Stage Trial of Lower-Dose Wegovy Pill for Weight Management

Oregon Study Finds Triple-Drug Regimen Kept Infant Macaques HIV-Free for One Year

Summit and Akeso Report Updated HARMONi Survival Data for Ivonescimab in Western NSCLC Patients

Roivant Sets Sights on Humira as Lisraya Performs Well in Eye Disease Study

BMS Reports Positive Phase 3 Results for Iza-Bren in Lung and Breast Cancer

BioNTech Reports Modest Benefit and Safety Concerns in Phase 3 Breast Cancer Trial

Disc Medicine’s Bitopertin Meets Phase 3 Goals in Rare Sunlight-Sensitivity Disorder

Menarini’s Stemline Signs Huge Deal With Georgiamine For Preclincal Cancer Drug

AstraZeneca Pens $1.5B Deal With Insitro Targeting Cardiometabolic Diseases

Merck to Acquire Silence Therapeutics for $1.3 Billion, Adding Experimental Blood Cancer Therapy

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Top 10 Metrics Clinical Operations Leaders Should Track

Real-Time Commercial Intelligence in Life Sciences

Top 10 AI Skills Every Life Sciences Leader Needs

Digital Therapeutics 2.0: The Next Phase of Software-Based Treatment

Tag: Trial Performance

Top 10 Metrics Clinical Operations Leaders Should Track

Editor Picks

Sanofi Becomes the Latest Drug Maker to Announce Insulin Price Cuts

Softbank now has $5B stake in Roche for its ability to develop drugs using data

AstraZeneca abandons phase 2 sickle cell medication and pays $185 million to rejoin the oral obesity gold rush market

Must Read

Top 10 Metrics Clinical Operations Leaders Should Track

Menarini’s Stemline Signs Huge Deal With Georgiamine For Preclincal Cancer Drug

Roivant Sets Sights on Humira as Lisraya Performs Well in Eye Disease Study

Hot Topics

About Us

Follow Us